Danaher Corporation (NYSE:DHR) announced it has entered into a definitive agreement to acquire Masimo Corporation (NASDAQ: ...

Feb 16 (Reuters) - Life sciences firm Danaher is closing in on a nearly $10 billion deal to acquire pulse oximeter maker ...

Danaher has struck an almost $10bn deal to buy patient monitoring company Masimo, two years after an activist investor ...

Irvine-based Masimo is being acquired by Danaher Corp. in a deal with an enterprise value of about $9.9 billion, allowing it ...

Why Danaher’s Price Target Just Nudged in the Other Direction Danaher’s fair value estimate has been reset slightly lower to ...

Danaher Corp. is nearing a roughly $10 billion deal to acquire US medical technology firm Masimo Corp., the Financial Times ...

On Tuesday, Danaher Corp (NYSE:DHR) reported third-quarter sales of $5.79 billion, up 3% year-over-year, beating the consensus of $5.59 billion. Non-GAAP core revenue increased by 0.5%, compared to ...

On Tuesday, Danaher Corp's DHR second quarter sales decreased 3% year-over-year to $$5.743 billion, beating the consensus of $5.59 billion. Non-GAAP core revenue decreased by 3.5%, compared to the ...

Danaher Corporation DHR is facing continued softness in its Life Sciences segment. In first-quarter 2025, core revenues from the segment declined 4% on a year-over-year basis. In the second quarter, ...